PUBLICATIONS AND PRESENTATIONS

Published Research Articles:

Barlow JF, Faris RJ, Wang W, Verbrugge RR, Garavaglia SB, Aubert RE. Impact of
specialty pharmacy on treatment costs for rheumatoid arthritis. Am J Pharm Benefits.
2012;4(Special Issue):SP49-SP56.
AK Jha, RE Aubert, J Yao, JR Teagarden, RS Epstein. Greater adherence to diabetes drugs
is linked to less hospital use and could save nearly $5 billion annually. Health Affairs. 2012
Aug; 31(8):1836-1846.
EJ Stanek, CL Sanders, KA Johansen Taber, M Khalid, A Patel, RR Verbrugge, BC Agatep,
RE Aubert, RS Epstein, FW Frueh. Adoption of pharmacogenomic testing by U.S.
physicians: results of a nationwide survey. Clin Pharmacol Ther. 2012 Mar;91(3):450-458.
Aubert RE, Herrera V, Chen W, Haffner SM, Pendergrass M. Rosiglitazone and pioglitazone
increase fracture risk in women and men with type 2 diabetes. Diabetes Obes Metab. 2010
Aug;12(8):716-21.
Aubert RE, Yao J, Xia F, Garavaglia SB. Is there a relationship between early statin
compliance and a reduction in healthcare utilization? Am J Manag Care. 2010 Jun;16(6):45966.
Epstein RS, Moyer TP, Aubert RE, O Kane DJ, Xia F, Verbrugge RR, Gage BF, Teagarden
JR. Warfarin genotyping reduces hospitalization rates results from the MM-WES (MedcoMayo Warfarin Effectiveness study). J Am Coll Cardiol. 2010 Jun 22;55(25):2804-12. Epub
2010 Apr 8.
Gellert KS, Aubert RE, Mikami JS. Ke 'Ano Ola: Moloka'i's community-based healthy
lifestyle modification program. Am J Public Health. 2010 May;100(5):779-83. Epub 2010
Mar 18.
Kreutz RP, Stanek EJ, Aubert RE, Yao J, Breall JA, Desta Z, Skaar TC, Teagarden JR,
Frueh FW, Epstein RS, Flockhart DA. Impact of Proton Pump Inhibitors on the
Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco
Outcomes Study. Pharmacotherapy 2010; 30(8):776-86.
Ortiz JR, Kamimoto L, Aubert RE, Yao J, Shay DK, Bresee JS, Epstein RS. Oseltamivir
prescribing in pharmacy-benefits database, United States, 2004-2005. Emerg Infect Dis
2008;14(8):1280-3.
Frueh FW, Amur S, Mummaneni P, Epstein RS, Aubert RE, DeLuca TM, Verbrugge RR,
Burckart GJ, Lesko LJ. Pharmacogenomic biomarker information in drug labels approved by
the United States food and drug administration: prevalence of related drug use.
Pharmacotherapy 2008; 28(8):992-8.
Castle L, Aubert RE, Verbrugge RR, Khalid M, Epstein RS. Trends in medication treatment
for ADHD. J Atten Disord 2007; 10(4):335-42.
Stettin GD, Yao, J, Verbrugge RR, Aubert RE. Frequency of Follow-up Care for Adult and
Pediatric Patients During the Initial Phase of Antidepressant Therapy. Am J Manag Care
2006;12:453-461.

Teagarden JR, Nagle B, Aubert RE, Wasdyke C, Courtney P, Epstein RS. Dispensing
error rate in a highly automated mail-service pharmacy practice. Pharmacotherapy
2005;25(5):1629-35.
Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims
data. Am J Manag Care 2005;11:449-457.
Aubert RE, Fulop G, Xia F, Thiel M, et al. Evaluation of a health management program to
improve outcomes in first or recurrent episode depression. Am J Manag Care.
2003;9(5):374-80.
Saadine JB, Beclkles GLA, Narayan KMV, Aubert RE, Klein R, Engelgau MM.
Prevalence of self-rated visual impairment among Adults with Diabetes - United States,
1995. Am. J. Pub Health, 1999;89:1200-1205.
Aubert RE, Waters J, Herman WH. Diabetes case management (letter). Ann of Intern
Med. 1999;130:862-3.
Sikka R, Waters J, Moore W, Sutton D, Herman WH, Aubert RE. Renal Assessment
Practices and the Effect of Nurse Case Management in HMO Patients with Diabetes
Mellitus, Diabetes Care 1999;22:1-6.
Herman WH, Aubert RE, Engelgau MM, Thompson TJ, Ali MA, et al. Diabetes mellitus
in Egypt: glycemic control and microvascular and neuropathic complications. Diabetic
Medicine 1998;15:1045-1051.
Aubert RE, Herman WH, Waters J, Moore W, Sutton D, Peterson BL, Bailey CM, Koplan
JP. A Randomized controlled Trial of Nurse Case Management within an HMO to
Improve Glycemic Control in Patients with Diabetes. Ann of Intern Med. 1998;129:605612.
King H, Aubert RE, Herman WH, Global Burden of Diabetes, 1995-2025: Prevalence,
Numerical Estimates and Projections. Diabetes Care 1998;21:1414-1431.
Beckles GLA, Engelgau MM, Venkat Narayan KM, Herman WH, Aubert RE, Williamson
DF. A Population-based Assessment of the Level of Care Among Adults with Diabetes
Mellitus in the U.S.. Diabetes Care 1998;21:1432-1438.
Aliotta SL, Aubert RE, A Managed Care Approach to High Risk Screening and Case
Management in the Elderly. Effective Clinical Practice 1998;1:93-94.
Herman WH, Aubert RE, Ali MA, Sous ES, Badrhan A. Diabetes mellitus in Egypt: risk
factors, prevalence and future burden. Eastern Mediterranean Health Journal, 3:144-148,
1997.
Engelgau MM, Thompson TJ, Herman WH, Boyle JP, Aubert RE, et. al. Comparison of
fasting and two-hour glucose and hemoglobin A1C levels for diagnosing diabetes:
diagnostic criteria and performance revisited. Diabetes Care 1997;20:785-791.
El-Hashimy MM, Aubert RE, Alich K, Warram JH, Harrigan BA, Herman WH. Strategies
to improve reporting of legal blindness in Massachusetts. AJPH 1997;87:425-428.

Herman WH, Ali MA, Aubert, RE, Engelgau MM, Kenny S, Malarcher AM, et. al.
Diabetes mellitus in Egypt - risk factors and prevalence. Diabetic Medicine, 12:11261131, 1995.
Engelgau MM, Aubert RE, Thompson TJ, Herman WH. Screening for NIDDM in nonpregnant adults: a review of principles, screening tests, and recommendations. Diabetes
Care 18:1606-1618, 1995.
Engelgau MM, Thompson TJ, Smith PJ, Herman WH, Aubert RE, Gunter E, Wetterhall
SF, Sous E, Ali MA. Screening for Diabetes Mellitus in Adults: The Utility of Random
Capillary Blood Glucose Measurements. Diabetes Care, 18:463-466,1995.
Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE. A new and simple
questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care
18:382-387, 1995.
Ford ES, Malarcher AM, Herman WH, Aubert RE. Diabetes mellitus and cigarette
smoking: findings from the 1989 National Health Interview Survey. Diabetes Care
17:688-692, 1994.
Book Chapters:
Aubert RE, Sikka R, Herman WH. Diabetes in Managed Care. In Medical Management of
Diabetes, Leahy JL and Cefalu W, Eds. Marcel Deckker, NY. 2000.
Aubert RE, Geiss LS, Ballard DJ, Cocanougher B, Herman WH. Diabetes-Related
Hospitalization and Hospital Utilization. In Diabetes in America, Harris MI, Ed. NIH,
Pub. No. 95-1468, 1995.
Kenny SJ, Aubert RE, Herman WH. Prevalence and Incidence of Diabetes Mellitus. In
Diabetes in America, Harris MI, Ed. NIH, Pub. No. 95-1468, 1995.
Manninen DL, Dasbach EJ, Dong FB, Aubert RE, Teutsch SM, Herman WH. Economic
evaluations of strategies for preventing renal disease in non-insulin dependent diabetes
mellitus. In The Kidney and Hypertension, 2nd edition, Mogensen CE, Editor, Kluwer
Academic Publishers, 1994, 63-73.

Other Publications:
Aubert RE. Global Burden of Diabetes, 1995-2025: Prevalence, Numerical Estimates and
Projections. Diabetes Care supplement, 90:147-156, 1997.
Aubert RE, Beckles GLA, Blount SB. Relationship between diabetes mellitus and other
factors for cardiovascular disease among men in a multiethnic community, St. James,
Trinidad. Diabetes, 44:833, 1995.
Beckles GLA, Aubert RE, Kenny SJ, Blount SB, Herman WH. The impact of diabetes
mellitus on cardiovascular disease among women in Trinidad, West Indies. Diabetes,
44:14, 1995.
Austin DF, Fu CX, Roffers SD, Shields JM, Aubert RE. Breast Cancer Mortality Model.
American Association of Central Cancer Registries. Emeryville, CA., 1993.
Qualters JR, Lee NC, Smith RA, Aubert RE. Breast and cervical cancer surveillance,
United States, 1973-1987. Centers for Disease Control. CDC Surveillance Summaries,
MMWR April 24, 1992;41(No. SS-2):1-15.
Cogswell ME, Waters J, Moore W, Aubert RE. Evaluation of a nurse case management
intervention in the control of diabetes. REPORT, vol. 2(3):5-6, Winter 1996.
Presentations:
Aubert RE, Epstein RS, Yao J, OKane DJ, Tinnirello J, Teagarden JR, Moyer TP.
Pharmacogenomic Testing for Warfarin Use in Typical Outpatient Settings Lowers
Healthcare Costs: The Medco-Mayo Warfarin Effectiveness Study (MM-WES).
International Society for Pharmacoeconomics and Outcomes Research 14th Annual
European Congress, Madrid, Spain, November 5-8, 2011.
Papademetriou E, Levin R, Tuennermann M, Lammers V, Aubert RE. Impact of an
Adherence Program, Run as a Telephone Intervention On Compliance With Subcutaneous
interferon -1A for Multiple Sclerosis Patients Using a Mail-Order Pharmacy.
International Society for Pharmacoeconomics and Outcomes Research 13th Annual
European Congress, Prague, Czech Republic, November 6-9, 2010
Levin R, Papademetriou E, Aubert RE. The Reliability of Proportion of Days Covered
Calculations Using Defined Daily Dose Estimates. International Society for
Pharmacoeconomics and Outcomes Research 13th Annual European Congress, Prague,
Czech Republic, November 6-9, 2010.
Wang W, Aubert RE. Co-pay Elimination Associated with Increased Medication
Utilization and Compliance with Asthma Medications. American Public Health
Association Annual Conference, November 6-10, Denver, 2010.
Outman RC, Markward NJ, Khalid M, Aubert RE, Curtis JR, Epstein RS, Frueh FW,
Stanek EJ, Steinkellner A, Warriner A, Saag KG. Screening and Treatment of
Glucocorticoid Induced Osteoporosis in a Large U.S. National Pharmacy Database.
American College of Rheumatology /ARHP Annual Scientific Meeting, Atlanta, GA,
November 6 -11, 2010.

Stanek EJ, Verbrugge R, Barlow J, Aubert RE, Khalid M, Frueh F, Epstein RS.
Nationwide Implementation and Adoption of Pharmacogenetic Testing Through a Novel
Pharmacy-Based Approach. American Society of Human Genetics 60th Annual Meeting,
Washington, DC, November 2-6, 2010.
Outman RC, Markward N, Khalid M, Aubert RE, Curtis JR, Epstein RS, Frueh FW, Stanek
EJ, Steinkellner A, Warriner A, Saag KG. Factors Associated with the Prevention of
Glucocorticoid-Induced Osteoporosis using a Large U.S. National Pharmacy Database.
American Society for Bone and Mineral Research 2010 Annual Meeting, Toronto, Ontario,
Canada, October 15-19, 2010.
Garavaglia SB, Khalid M, Bruno M, Nichols LA, Kagan SA, Castle L, Aubert RE.
Application of a National Prescription Database to Devise a Predictive Model for Tailoring
HIV/AIDS Therapeutic Management. International Society for Pharmacoeconomics and
Outcomes Research 15th Annual International Meeting, Washington, D.C., May 15-19,
2010.
Herrera V, Aubert RE, Tully L, Tao Z, Stettin G, Bhandari I, Pendergrass M. Pancreatitis
in patients treated with Exenatide or Sitagliptin. American Diabetes Association 69th
Scientific Sessions, New Orleans, June 5 9, 2009.
Aubert RE, Herrera V, Tully L, Tao Z, Stettin G, Bhandari I, Haffner S, Pendergrass M.
Thiazolidinedione Treatment and the Risk of Fracture. American Diabetes Association 69th
Scientific Sessions, New Orleans, June 5 9, 2009.
Aubert RE, Stanek EJ, Yao J, Teagarden JR, Epstein RS, , Desta Z, Skaar T, Flockhart DA.
Increased Risk Of Breast Cancer Recurrence In Women Initiating Tamoxifen With
CYP2D6 Inhibitors. American Society for Clinical Oncology Scientific Sessions 2009,
Orlando, May 28 - June 2nd, 2009.
Aubert RE, Stanek EJ, Yao J, Freuh F, Epstein ES. The Impact Of Proton Pump Inhibitors
On Cardiovascular-Related Event Costs In Patients Initiating Clopidogrel. International
Society for Pharmacoeconomics and Outcomes Research 14th Annual International
Meeting, Orlando, May 16 - 20, 2009.
Stanek EJ, Aubert RE, Flockhart DA, Kreutz RP, Yao J, Breall J, Desta Z, Skaar T, Frueh
F, Teagarden RJ, Epstein RS. A National Study of the Effect of Individual proton Pump
Inhibitors on Cardiovascular Outcomes in Patients Treated with Clopidogrel Following
Coronary Stenting: The Clopidogrel Medco Outcomes Study. The Society for
Cardiovascular Angiography and Interventions 32nd Annual Scientific Sessions, Las Vegas
May 6 9, 2009.
Stanek EJ, Aubert RE, Epstein RS, Teagarden JR, Xia F, Yao J, Desta Z, Skaar T,
Flockhart DA. Proton Pump Inhibitors in the Absence of Clopidogrel Therapy Do Not
Affect Cardiovascular Outcomes in Coronary Stent Patients. Quality of Care and
Outcomes Research in Cardiovascular Disease and Stroke Conference, Baltimore April 23
25, 2009.
Dasmahapatra A, Wang W, Toste C, Steinkellner A, Khalid M, Barlow J, Aubert. Copay
Reductions Associated with Increased medication Compliance and Persistency. Academy
of Managed Care Pharmacy 21st Annual meeting and Showcase, Orlando, FL April 15
18, 2009.

Aubert RE. Personalized Diagnostics. Value in Health Care: Accounting for Cost,
Quality, Safety, Outcomes and Innovation A learning Healthcare System Series Workshop
IOM Roundtable on Evidence-Based Medicine, Washington, DC November 17 18, 2008.
Aubert RE, Epstein RS, Teagarden JR, Xia F, Yao J, Desta Z, Skaar T, Flockhart DA.
Proton Pump Inhibitors Effect on Clopidogrel Effectiveness: The Clopidogrel Medco
Outcomes Study. American Heart Association Scientific Sessions 2008. New Orleans,
November 8 12, 2008.
Wang W, Khalid M, Chopra-Mehta S, Sungela G, Aubert R. Impact of Consumer Directed
Health Plan Selection on Medication Adherence. Academy Health 25th Annual Research
Meeting, Washington D.C., June 8 20, 2008
Perez N, Dasmahapatra A, Khalid, Aubert RE. Age and Sex Differences in Children in
Type 2 Diabetes. American Diabetes Association 67th Annual Meeting and Scientific
Sessions. Chicago, June 22-26, 2007.
Perez N, Dasmahapatra A, Khalid, Aubert RE. Trends in Childhood Diabetes. CDC
Diabetes Translation Conference, Atlanta, April 30 May 2, 2007.
Sikka R, Levin RJ, Aubert RE. Predicting Diabetes Medication Discontinuation from
Pharmacy Claims Data. American Diabetes Association 64th Annual Meeting and
Scientific Sessions. Orlando, June 4-8, 2004.
Levin RJ, Sikka R, Aubert RE. Medication Adherence and Concomitant Therapy.
International Society for Pharmacoeconomic and Outcomes Research 9th Annual Meeting.
Arlington, May 17-19, 2004.
Sikka R, Khalid M, Chae E, Alemayehu B, Aubert RE. Impact of the Anthrax
Bioterrorism Incidents of 2001 on Antibiotic Utilization. 8th Annual New England
Regional Society for Academic Emergency Medicine Meeting, April 28, 2004.
Aubert RE, Xia F, Woo C, Fulop G. Impact of Depression Disease Management on
Depression Outcomes and QoL. American Psychiatric Association 156th Annual Meeting.
San Francisco, May 17-23, 2003.
Eastman RC, Sikka R, Aubert RE, Battista O. Prediction of the Risk of Complications by
Age at Diagnosis of Diabetes. American Diabetes Association 60th Annual Meeting and
Scientific Sessions. San Antonio, June 9-13, 2000.
Aubert RE, Hooter L, Garcia M, Scott T. Nurse Case Management Improves Glycemic
Control in Hispanic HMO Patients with Diabetes Mellitus: A Randomized Controlled
Trial. American Diabetes Association 60th Annual Meeting and Scientific Sessions. San
Antonio, June 9-13, 2000.
Aubert RE. Effective Models for Diabetes Management. State of Hawaii Diabetes
Control Program Strategic Planning Meeting. Honolulu, May 4, 2000.
Scott TL, Aubert RE. The Effect of Nurse Case Management on Diabetes SelfManagement Among HMO Patients in a Randomized Trial. American Diabetes
Association 59th Annual Meeting and Scientific Sessions. San Diego, June 19-22, 1999.

Aubert, RE, Herman WH, Peterson L, Koplan JP. The Use of Nurse Case Management
Improves Glycemic Control in HMO Patients with Diabetes Mellitus: A Randomized
Controlled Trial. American Diabetes Association 58th Annual Meeting and Scientific
Sessions. Chicago, June 13-16, 1998.
Sikka R, Aubert RE, Herman WH. Nurse Case Management Improves Renal Assessment
in HMO Patients with Diabetes Mellitus. American Diabetes Association 58th Annual
Meeting and Scientific Sessions. Chicago, June 13-16, 1998.
Scott TL, Aubert RE. The Relationship Between Glycemic Control and Quality of Life
Among HMO Patients with Diabetes Mellitus in a Randomized Trial. American Diabetes
Association 58th Annual Meeting and Scientific Sessions. Chicago, June 13-16, 1998.
Aubert, RE. Population-based Health Outcomes Research. National Managed Health
Care Congress, Atlanta, April 23, 1998.
Aubert, RE. Symposium: Identifying Best Practices for Proper Intervention in Diabetes
Management. Second Annual Disease Management Congress, Washington, D.C.,
September 2, 1997.
Waters J, Aubert RE. Evaluation of nurse case management for the control of diabetes
mellitus. American Association of Diabetes Educators, 24th Annual Meeting. Denver,
August 23, 1997.
Aubert, RE. Trends in the Global Burden of Diabetes, 1995-2025. American Diabetes
Association 57th Annual Meeting and Scientific Sessions. Boston, June 21-24, 1997.
Aubert RE, Waters J, Moore W, Sutton D. Evaluating a nurse case management system
for comprehensive diabetes care. CDC Managed Care Seminar Series: Fundamentals of
Managed Care for Public Health Professionals, Satellite Symposium, October 24, 1996.
Aubert RE, Waters J, Moore W, Sutton D. Evaluating a nurse case management system
for comprehensive diabetes care. NIDDK/CDC National Diabetes Education Program
Payers Focus Group. September 16, 1996.
Waters J, Cogswell ME, Moore W, Aubert RE. A nurse case management system for
providing comprehensive diabetes care: translating guidelines into practice. American
Association of Diabetes Educators 23rd Annual Meeting. New Orleans, August 24, 1996.
Beckles GLA, Aubert RE, Herman WH. The impact of hypertension on cardiovascular
disease among women with and without diabetes in Trinidad, West Indies. The St. James
study. Tenth International Conference on Hypertension in Blacks. St. Thomas, U.S.
Virgin Islands, June 1995.
Aubert RE. Diabetes patient and physician perspectives: results of community and
national surveys. Diabetes Performance Measures and Treatment Programs: Solutions for
the Patient, Prevention: The Annual National Preventive Medicine Conference.
New Orleans, 1995.
Aubert RE. The BRFSS diabetes module: establishing national diabetes surveillance
capacity. Translation Strategies Workshop, Division of Diabetes Translation, Centers for
Disease Control and Prevention Annual Conference. Atlanta, September 1994.

Aubert RE. Concepts of population-based screening. Translation Strategies Workshop,

Division of Diabetes Translation, Centers for Disease Control and Prevention Annual
Conference. Atlanta, September 1994.
Aubert RE. "The burden of undiagnosed NIDDM, principles of screening and assessment
of screening test performance". Council on Epidemiology and Statistics, 54th Annual
Meeting and Scientific Sessions of the American Diabetes Association, New Orleans, June
1994.
Beckles GLA, Aubert RE. "Relationship Between Diabetes Mellitus and Other Risk
Factors for Cardiovascular Disease among Women of African, Asian Indian and Mixed
Origin in St. James Trinidad". Eighth, International Conference on Hypertension in
Blacks, Yaounde, Cameroon, April 1993.
Aubert RE, Blount SB. Hypertension and diabetic renal disease co-mortality in the United
States, 1980-1988. Sixth international interdisciplinary conference on hypertension in
blacks. Salvador, Bahia, Brazil, 1991.
Aubert RE, Blount SB. Correlates of hypertension and diabetic renal disease co-mortality
in the United States, 1988. Sixth international interdisciplinary conference on hypertension
in blacks. Salvador, Bahia, Brazil, 1991.
Blount SB, Aubert RE. Hypertension related mortality among the elderly in the United
States, 1980-1988. Sixth international interdisciplinary conference on hypertension in
blacks. Salvador, Bahia, Brazil, 1991.
Aubert RE, Blount SB. Variability of hypertensive renal disease related mortality in the
United States, 1968-1987. Fifth international interdisciplinary conference on hypertension
in blacks. Long Beach, California, 1990.
Aubert RE, Blount SB, Rothenberg RB. Variability of hypertension related mortality in
the United States, 1968-1986. Fourth international interdisciplinary conference on
hypertension in blacks. Nairobi, Kenya, 1989.
Aubert RE, Parker RA, Rothenberg RB, May DS. Methodologic issues in the reported
prevalence of Alzheimer's Disease on death certificates. The 1987 conference on records
and statistics. Washington, D.C., 1987.